Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Genetics

Building Your Care Team & Surveillance

At a Glance

Managing Classic Galactosemia requires a multidisciplinary care team led by a metabolic geneticist. Ongoing surveillance is critical and includes regular monitoring of Gal-1-P levels, eye exams for cataracts, DEXA scans for bone density, and specialized screenings for speech delays and ovarian function.

Because Classic Galactosemia affects multiple systems—from the eyes and bones to the brain and reproductive system—your child cannot be managed by a general pediatrician alone [1][2]. You will need to build a multidisciplinary care team to provide what is known as a “metabolic home” for your child [3][4].

The Core Specialists

Each member of your team has a specific role in preventing or managing potential complications [1][5]:

  • Metabolic Geneticist: The “quarterback” of the team. They monitor your child’s enzyme levels and manage the overall diagnosis [3].
  • Specialized Metabolic Dietitian: Essential for managing the restricted diet, ensuring proper nutrition, and providing guidance on safe, aged cheeses [6][7].
  • Pediatric Endocrinologist: Focuses on bone health and, for girls, monitors ovarian function and puberty [8][9].
  • Speech-Language Pathologist (SLP): Should be involved early to screen for Childhood Apraxia of Speech and other language delays [10].
  • Pediatric Neurologist: Monitors for motor issues like tremors or ataxia (balance problems) [11][12].
  • Ophthalmologist: Screens for cataracts, which can develop due to sugar buildup in the lens [13].

Recommended Surveillance Timeline

Ongoing monitoring is the best way to catch issues early. While your doctor will set a personalized schedule, the following is generally recommended by international guidelines [7][5]:

Evaluation Frequency Purpose
Gal-1-P Levels Every 3–6 months in infancy; then annually Monitoring galactose-1-phosphate (the toxic byproduct of the disease) to check internal sugar levels and dietary compliance [7][14].
Developmental Screening Every visit during early childhood Proactively identifying the need for physical, occupational, or speech therapy (like Babble Boot Camp) [15][16].
Eye Exam At diagnosis, then as recommended by specialist Screening for and monitoring cataracts [13].
AMH & FSH Labs Starting in late childhood/early puberty (females) Monitoring for Primary Ovarian Insufficiency [8][9].
DEXA Scan Periodically starting in childhood/adolescence Measuring bone mineral density to prevent osteoporosis [17][5].
Neuropsych Testing Before starting school and at major transitions Identifying learning needs for IEPs or 504 plans [1][16].

Vetting Your Care Team

Galactosemia is a rare “orphan” disease. It is okay—and even necessary—to ask questions to ensure your doctors have the expertise to help your child. A strong care team should be familiar with current GalNet (International Galactosemia Network) guidelines and be willing to collaborate with specialists at major research hospitals [18][19].

If you live in an area without a metabolic specialist, your local team should be willing to consult with a regional “Center of Excellence” to coordinate care [4]. Proactive surveillance is not about looking for trouble; it is about staying one step ahead of the condition [20][7].

Common questions in this guide

Which specialists should be on a galactosemia care team?
A comprehensive care team usually includes a metabolic geneticist, a specialized metabolic dietitian, a pediatric endocrinologist, a speech-language pathologist, a pediatric neurologist, and an ophthalmologist. Each specialist plays a role in preventing or managing potential complications.
How often should Gal-1-P levels be checked in a child with galactosemia?
Galactosemia-1-phosphate (Gal-1-P) levels are typically checked every 3 to 6 months during infancy, and then annually. This helps doctors monitor the toxic byproduct of the condition and ensure the restricted diet is working effectively.
Why do girls with galactosemia need to see an endocrinologist?
Females with classic galactosemia are at high risk for a complication called Primary Ovarian Insufficiency. An endocrinologist will monitor ovarian function and puberty by checking AMH and FSH hormone levels starting in late childhood or early puberty.
What are the GalNet guidelines for galactosemia?
GalNet stands for the International Galactosemia Network. This organization creates the international consensus guidelines for the long-term monitoring and care of patients with galactosemia, ensuring they receive the most up-to-date, standardized treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with Classic Galactosemia do you currently manage?
  2. 2.Do you follow the GalNet international consensus guidelines for long-term monitoring?
  3. 3.Can you coordinate with a metabolic dietitian to ensure my child's calcium intake and 'safe cheese' options are optimized?
  4. 4.What is your protocol for transition-of-care once my child reaches adulthood?
  5. 5.Is our local hospital equipped to manage a metabolic crisis, and who should I call after hours?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

    Treacy EP, Vencken S, Bosch AM, et al.

    JIMD reports 2021; (61(1)):76-88 doi:10.1002/jmd2.12237.

    PMID: 34485021
  2. 2

    Galactose-1-phosphate uridyltransferase deficiency: A literature review of the putative mechanisms of short and long-term complications and allelic variants.

    Viggiano E, Marabotti A, Politano L, Burlina A

    Clinical genetics 2018; (93(2)):206-215 doi:10.1111/cge.13030.

    PMID: 28374897
  3. 3

    Metabolic Evaluation of Epilepsy: A Diagnostic Algorithm With Focus on Treatable Conditions.

    van Karnebeek CDM, Sayson B, Lee JJY, et al.

    Frontiers in neurology 2018; (9()):1016 doi:10.3389/fneur.2018.01016.

    PMID: 30559706
  4. 4

    The role of integrated behavioral health in caring for patients with metabolic disorders.

    Soares N, Apple RW, Kanungo S

    Annals of translational medicine 2018; (6(24)):478 doi:10.21037/atm.2018.10.62.

    PMID: 30740409
  5. 5

    The natural history of classic galactosemia: lessons from the GalNet registry.

    Rubio-Gozalbo ME, Haskovic M, Bosch AM, et al.

    Orphanet journal of rare diseases 2019; (14(1)):86 doi:10.1186/s13023-019-1047-z.

    PMID: 31029175
  6. 6

    Elevated urine oxalate and renal calculi in a classic galactosemia patient on soy-based formula.

    Sabatino JA, Starin D, Tuchman S, et al.

    JIMD reports 2019; (49(1)):7-10 doi:10.1002/jmd2.12056.

    PMID: 31497475
  7. 7

    The Importance of Neonatal Screening for Galactosemia.

    Badiu Tișa I, Achim AC, Cozma-Petruț A

    Nutrients 2022; (15(1)) doi:10.3390/nu15010010.

    PMID: 36615667
  8. 8

    Pathophysiology and management of classic galactosemic primary ovarian insufficiency.

    Hagen-Lillevik S, Rushing JS, Appiah L, et al.

    Reproduction & fertility 2021; (2(3)):R67-R84 doi:10.1530/RAF-21-0014.

    PMID: 35118398
  9. 9

    Early postnatal alterations in follicular stress response and survival in a mouse model of Classic Galactosemia.

    Hagen-Lillevik S, Johnson J, Lai K

    Journal of ovarian research 2022; (15(1)):122 doi:10.1186/s13048-022-01049-2.

    PMID: 36414970
  10. 10

    Identification of neuronal structures and pathways corresponding to clinical functioning in galactosemia.

    Ahtam B, Waisbren SE, Anastasoaie V, et al.

    Journal of inherited metabolic disease 2020; (43(6)):1205-1218 doi:10.1002/jimd.12279.

    PMID: 32592186
  11. 11

    Myo-Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study.

    Niess E, Niess F, Bogner W, et al.

    Journal of inherited metabolic disease 2025; (48(6)):e70097 doi:10.1002/jimd.70097.

    PMID: 41083920
  12. 12

    Folate deficiency in patients with classical galactosemia: A novel finding that needs to be considered for dietary treatments.

    Çelik M, Özgün N, Akdeniz O, et al.

    The Turkish journal of pediatrics 2018; (60(5)):540-546.

    PMID: 30968626
  13. 13

    Novel GALT variations and genetic spectrum in Turkish population with the correlation of genotype and phenotype.

    Kalay I, Gulec C, Balcı MC, et al.

    Annals of human genetics 2023; (87(6)):285-294 doi:10.1111/ahg.12523.

    PMID: 37563963
  14. 14

    Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate.

    Cohen AS, Baurek M, Lund AM, et al.

    International journal of neonatal screening 2019; (5(2)):19 doi:10.3390/ijns5020019.

    PMID: 33072978
  15. 15

    Toward Preventing Speech and Language Disorders of Known Genetic Origin: First Post-Intervention Results of Babble Boot Camp in Children With Classic Galactosemia.

    Peter B, Davis J, Cotter S, et al.

    American journal of speech-language pathology 2021; (30(6)):2616-2634 doi:10.1044/2021_AJSLP-21-00098.

    PMID: 34665663
  16. 16

    Motor Milestones: Sensory Motor Trends of Young Children with Classic Galactosemia.

    Armstrong-Heimsoth A, Monroe A, Cupp C, et al.

    Journal of occupational therapy, schools & early intervention 2024; (17(2)):216-227 doi:10.1080/19411243.2023.2192206.

    PMID: 39185447
  17. 17

    Primary ovarian insufficiency in Classic Galactosemia: a systematic review.

    Candela E, Montanari G, Di Blasi E, et al.

    Journal of endocrinological investigation 2025; (48(6)):1303-1315 doi:10.1007/s40618-024-02527-8.

    PMID: 39821528
  18. 18

    A Global Survey of Dietitians' Perspectives and Implementation of the International Clinical Guidelines for Classical Galactosaemia.

    Wong E, Robertson L

    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association 2025; (38(5)):e70141 doi:10.1111/jhn.70141.

    PMID: 41063508
  19. 19

    Dietetic management of adults with Classical Galactosaemia in the UK: A care consensus document.

    Robertson L, Tapley S, Sparks A, et al.

    Molecular genetics and metabolism reports 2025; (45()):101277 doi:10.1016/j.ymgmr.2025.101277.

    PMID: 41323098
  20. 20

    Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta.

    Almenabawy N, Bahl S, Ostlund AL, et al.

    Molecular genetics and metabolism reports 2024; (38()):101055 doi:10.1016/j.ymgmr.2024.101055.

    PMID: 38469090

This page provides educational information about building a care team and surveillance guidelines for Galactosemia. Always consult your metabolic geneticist and healthcare team for personalized medical advice and monitoring schedules.

Get notified when new evidence is published on Galactosemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.